APA (7th ed.) Citation

Yacob, A. M., Muhamad, N. A., Chang, K. M., Hisham, H. A., Yusoff, Y. M., & Ibrahim, L. (2022). Hsa-miR-181a-5p, hsa-miR-182-5p, and hsa-miR-26a-5p as potential biomarkers for BCR-ABL1 among adult chronic myeloid leukemia treated with tyrosine kinase inhibitors at the molecular response. BMC.

Chicago Style (17th ed.) Citation

Yacob, Aliza Mohd, Nor Asiah Muhamad, Kian Meng Chang, Hamidah Akmal Hisham, Yuslina Mat Yusoff, and Latifah Ibrahim. Hsa-miR-181a-5p, Hsa-miR-182-5p, and Hsa-miR-26a-5p as Potential Biomarkers for BCR-ABL1 Among Adult Chronic Myeloid Leukemia Treated with Tyrosine Kinase Inhibitors at the Molecular Response. BMC, 2022.

MLA (9th ed.) Citation

Yacob, Aliza Mohd, et al. Hsa-miR-181a-5p, Hsa-miR-182-5p, and Hsa-miR-26a-5p as Potential Biomarkers for BCR-ABL1 Among Adult Chronic Myeloid Leukemia Treated with Tyrosine Kinase Inhibitors at the Molecular Response. BMC, 2022.